Metabolism of serotonin
|
|
|
|
|
Transport of fatty acids
|
|
|
- ACSVL2
- ACSVL4
- ACSVL5
- APOD
- FACVL2
- FATP1
- FATP4
- FATP6
- LCN1
- LCN12
- LCN15
- LCN9
- SLC27A1
- SLC27A4
- SLC27A6
- VEGP
|
|
Hereditary fructose intolerance
|
|
|
|
|
Toxicity of tetanus toxin (tetX)
|
|
|
|
|
Maturation of spike protein
|
- Alpha-(1,6)-fucosyltransferase
- Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase
- Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A
- Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B
- Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C
- Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase
- Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A
- Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase
- Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2
- Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3
- Alpha-mannosidase 2
- Beta-galactoside alpha-2,6-sialyltransferase 1
- CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase
- CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1
- CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2
- CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4
- Calnexin
- Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit
- Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1
- Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2
- Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1
- Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A
- ER degradation-enhancing alpha-mannosidase-like protein 2
- Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase
- Glucosidase 2 subunit beta
- Golgin subfamily A member 7
- Magnesium transporter protein 1
- Mannosyl-oligosaccharide glucosidase
- Neutral alpha-glucosidase AB
- Palmitoyltransferase ZDHHC11
- Palmitoyltransferase ZDHHC20
- Palmitoyltransferase ZDHHC2
- Palmitoyltransferase ZDHHC3
- Palmitoyltransferase ZDHHC5
- Palmitoyltransferase ZDHHC8
- Palmitoyltransferase ZDHHC9
- Spike glycoprotein
- Tumor suppressor candidate 3
|
|
- C20orf31
- C20orf49
- CANX
- CGS23
- CXorf11
- DAD1
- DDOST
- EDEM2
- FUT8
- G19P1
- G2AN
- GANAB
- GCP16
- GCS1
- GGNT1
- GGNT5
- GLCT1
- GLYT1
- GOLGA7
- IAG2
- ITM1
- KIAA0088
- KIAA0115
- KIAA1292
- KIAA1748
- MAGT1
- MAN1B1
- MAN2A1
- MANA2
- MGAT
- MGAT1
- MGAT2
- MGAT4A
- MGAT4B
- MGAT4C
- MGAT5
- MOGS
- N33
- NANTA3
- OST48
- PRKCSH
- REAM
- REC
- RPN1
- RPN2
- S
- SIAT1
- SIAT3C
- SIAT4
- SIAT4A
- SIAT4B
- SIAT4C
- SIAT6
- SIAT7B
- SIAT7C
- SIAT7D
- SIATL1
- ST3GAL1
- ST3GAL2
- ST3GAL3
- ST3GAL4
- ST6GAL1
- ST6GALNAC2
- ST6GALNAC3
- ST6GALNAC4
- STHM
- STT3A
- STZ
- TMC
- TUSC3
- ZDHHC10
- ZDHHC11
- ZDHHC2
- ZDHHC20
- ZDHHC3
- ZDHHC5
- ZDHHC8
- ZDHHC9
- ZDHHCL1
- ZNF372
- ZNF375
- ZNF378
- ZNF379
- ZNF380
- ZNF399
|
|
Asparagine N-linked glycosylation
|
|
|
- ASGR1
- ASGR2
- B4GALNT2
- CLEC4H1
- CLEC4H2
- DAD1
- DDOST
- GALGT2
- IAG2
- ITM1
- KIAA0115
- MAGT1
- N33
- OST48
- RPN1
- RPN2
- STT3A
- TMC
- TUSC3
- UMOD
|
|
Cross-presentation of particulate exogenous antigens (phagosomes)
|
|
|
- CD36
- CYBA
- CYBB
- GP3B
- GP4
- ITGAV
- ITGB5
- MSK8
- NCF1
- NCF2
- NCF4
- NOX2
- NOXA2
- NOXO2
- P67PHOX
- SH3PXD1A
- SH3PXD4
- VNRA
- VTNR
|
|
RHO GTPases Activate NADPH Oxidases
|
|
|
- CAGA
- CAGB
- CFAG
- CSBP
- CSBP1
- CSBP2
- CSPB1
- CYBA
- CYBB
- ERK1
- ERK2
- MAPK1
- MAPK11
- MAPK14
- MAPK3
- MOX1
- MOX2
- MRP14
- MRP8
- MXI2
- NCF1
- NCF2
- NCF4
- NOH1
- NOX1
- NOX2
- NOX3
- NOXA1
- NOXA2
- NOXO1
- NOXO2
- P41NOX
- P51NOX
- P67PHOX
- PIK3C3
- PIK3R4
- PIN1
- PKC2
- PKCA
- PKCB
- PKCD
- PRKACA
- PRKCA
- PRKCB
- PRKCB1
- PRKCD
- PRKCZ
- PRKM1
- PRKM11
- PRKM2
- PRKM3
- RAC1
- RAC2
- S100A8
- S100A9
- SAPK2
- SAPK2A
- SAPK2B
- SH3PXD1A
- SH3PXD4
- SH3PXD5
- TC25
- VPS15
- VPS34
|
|
Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)
|
|
|
- CYP1A1
- CYP1A2
- CYP1B1
- CYP2C10
- CYP2C19
- CYP2C8
- CYP2C9
- CYP2U1
- CYP4A11
- CYP4A2
- CYP4F2
|
|
Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)
|
|
|
- CYP1A1
- CYP1A2
- CYP1B1
- CYP2C10
- CYP2C19
- CYP2C8
- CYP2C9
- CYP2J2
- EPHX2
|
|
Biosynthesis of protectins
|
|
|
- ALOX15
- CYP1A1
- CYP1A2
- LOG15
- LTA4
- LTA4H
|
|
Loss of function of TP53 in cancer due to loss of tetramerization ability
|
|
|
|
|
Activation of NOXA and translocation to mitochondria
|
|
|
- DP1
- DP2
- E2F1
- NOXA
- P53
- PMAIP1
- RBBP3
- TFDP1
- TFDP2
- TP53
|
|
PI5P Regulates TP53 Acetylation
|
|
|
- C14orf9
- EP300
- ING1L
- ING2
- MAP2K6
- MEK6
- MKK6
- P300
- P53
- PI5P4KA
- PIN1
- PIP4K2A
- PIP4K2B
- PIP4K2C
- PIP4P1
- PIP5K2
- PIP5K2A
- PIP5K2B
- PIP5K2C
- PRKMK6
- SKK3
- TMEM55B
- TP53
|
|
Transcriptional activation of cell cycle inhibitor p21
|
|
|
- CAP20
- CDKN1
- CDKN1A
- CIP1
- HZF
- MDA6
- P53
- PCBP4
- PIC1
- RZF
- SDI1
- TP53
- WAF1
- ZNF385
- ZNF385A
|
|
Formation of Senescence-Associated Heterochromatin Foci (SAHF)
|
|
|
- ASF1A
- CABIN1
- CAGH32
- DGCR1
- EP400
- H1-0
- H1-1
- H1-2
- H1-3
- H1-4
- H1-5
- H1F0
- H1F1
- H1F2
- H1F3
- H1F4
- H1F5
- H1FV
- HIR
- HIRA
- HIST1H1A
- HIST1H1B
- HIST1H1C
- HIST1H1D
- HIST1H1E
- HMGA1
- HMGA2
- HMGIC
- HMGIY
- KIAA0330
- KIAA1498
- KIAA1818
- LMN2
- LMNB
- LMNB1
- P53
- RB1
- TNRC12
- TP53
- TUPLE1
- UBN1
|
|
NGF-independant TRKA activation
|
|
|
- ADCYAP1
- ADCYAP1R1
- ADORA2
- ADORA2A
- MTC
- NTRK1
- NTRK2
- TRK
- TRKA
- TRKB
|
|
Resistance of ERBB2 KD mutants to lapatinib
|
|
|
- CDC37
- CDC37A
- ERBB2
- ERBB2IP
- ERBIN
- HER2
- HSP90A
- HSP90AA1
- HSPC1
- HSPCA
- KIAA1225
- LAP2
- MLN19
- NEU
- NGL
|
|
Resistance of ERBB2 KD mutants to sapitinib
|
|
|
- CDC37
- CDC37A
- ERBB2
- ERBB2IP
- ERBIN
- HER2
- HSP90A
- HSP90AA1
- HSPC1
- HSPCA
- KIAA1225
- LAP2
- MLN19
- NEU
- NGL
|
|
Resistance of ERBB2 KD mutants to AEE788
|
|
|
- CDC37
- CDC37A
- ERBB2
- ERBB2IP
- ERBIN
- HER2
- HSP90A
- HSP90AA1
- HSPC1
- HSPCA
- KIAA1225
- LAP2
- MLN19
- NEU
- NGL
|
|
Drug-mediated inhibition of ERBB2 signaling
|
|
|
- CDC37
- CDC37A
- ERBB2
- ERBB2IP
- ERBIN
- HER2
- HSP90A
- HSP90AA1
- HSPC1
- HSPCA
- KIAA1225
- LAP2
- MLN19
- NEU
- NGL
|
|
Resistance of ERBB2 KD mutants to tesevatinib
|
|
|
- CDC37
- CDC37A
- ERBB2
- ERBB2IP
- ERBIN
- HER2
- HSP90A
- HSP90AA1
- HSPC1
- HSPCA
- KIAA1225
- LAP2
- MLN19
- NEU
- NGL
|
|
Drug resistance in ERBB2 TMD/JMD mutants
|
|
|
- CDC37
- CDC37A
- ERBB2
- ERBB2IP
- ERBIN
- HER2
- HSP90A
- HSP90AA1
- HSPC1
- HSPCA
- KIAA1225
- LAP2
- MLN19
- NEU
- NGL
|
|
Resistance of ERBB2 KD mutants to trastuzumab
|
|
|
- CDC37
- CDC37A
- ERBB2
- ERBB2IP
- ERBIN
- HER2
- HSP90A
- HSP90AA1
- HSPC1
- HSPCA
- KIAA1225
- LAP2
- MLN19
- NEU
- NGL
|
|
Resistance of ERBB2 KD mutants to afatinib
|
|
|
- CDC37
- CDC37A
- ERBB2
- ERBB2IP
- ERBIN
- HER2
- HSP90A
- HSP90AA1
- HSPC1
- HSPCA
- KIAA1225
- LAP2
- MLN19
- NEU
- NGL
|
|